The gtg announcement in 2009 pertains to their sales agreements with Rosetta not the Medicare accreditation.
The real positive news for Rosetta and GTG is that Medicare will now pay for these tests. Much harder to get money from patients when it costs money versus a free test. N
This is huge news and will ultimately result in a big re rating. Stock was up yesterday so just consolidating around here.
rosetta genomics in usa no announcement here?, page-11
Add GTG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.671M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| GTG (ASX) Chart |
Day chart unavailable